Related Experiment Video
Updated: Nov 6, 2025

09:38
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
12.9K
Characterizing Pain Points in Clinical Data Management and Assessing the Impact of Mid-Study Updates
Beth Harper1, Zachary Smith2, Jane Snowdon3
1Clinical Performance Partners, Aurora, IL, USA.
Therapeutic Innovation & Regulatory Science
|May 8, 2021
Summary
Mid-study database updates in clinical trials are disruptive and time-intensive. Managing these challenges is crucial for improving efficiency as data volume and complexity grow.
Area of Science:
- Clinical data management
- Drug development operations
Background:
- Evaluated causes, degree, and disruptive nature of mid-study database updates.
- Assessed clinical data management's response to increasing data volume and diversity.
Purpose of the Study:
- To understand the impact of mid-study database updates.
- To identify challenges in managing clinical trial data.
Main Methods:
- Conducted a global online survey (September-October 2020) in collaboration with IBM Watson Health.
- Analyzed 194 verified responses from clinical trial professionals.
Main Results:
- Mid-study database updates (planned and unplanned) are the primary challenges.
- An average of 4.1 planned and 3.7 unplanned updates occurred per trial.
- Management of these updates was found to be time-intensive.
Conclusions:
- Mid-study database updates significantly disrupt clinical trial processes.
- Addressing these disruptions offers a key opportunity to enhance efficiency and accelerate cycle times.
- Increasing protocol flexibility and data diversity necessitate improved data management strategies.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
218
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
218
Analgesia and Pain Management
1.1K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.1K
Therapeutic Drug Monitoring: Affecting Factors
51
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
51
Pharmacovigilance
1.3K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.3K
Methods of Documentation VI: Case Management Model
684
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
684
Clinical Trials
9.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
9.9K

